We're excited to announce the combination of Berkeley Lights and IsoPlexis, bringing together the Beacon and IsoSpark platforms to form the premier functional cell biology company. Visit Site

Resource

Webinar: Accelerating Antibody Discovery in the Modern Therapeutic Landscape

Download File

Related Resources

View All Resources
Antibody Discovery

Webinar: Opto™ Plasma B Discovery 4.0 Fireside Chat

Join members of our Opto Plasma B Discovery 4.0 development team for a panel discussion about our latest antibody discovery workflow.
Antibody Discovery Cell Line Development T Cell Profiling Beacon System

BROCHURE: Beacon Quest™ Optofluidic System for Academic Research

The Beacon Quest™ is an automated 2-chip optofluidic system that allows you to run thousands of miniaturized single-cell assays in parallel and then recover cells of interest.
Antibody Discovery Cell Line Development

Customer Spotlight: Amgen on the Berkeley Lights Platform

Philip Tagari, VP Therapeutic Discovery, Amgen, discusses how the Berkeley Lights’ platform has transformed the way Amgen approaches antibody discovery and cell line development.